Menu
wave-1
Clinical Evidence · HAIR BENEFITS

Hair visibly restored

68.9%

REDUCTION IN HAIR LOSS
(WITHOUT BULB COUNT)
hair-loss

Hair Loss

In a 75-day randomised, double-blind, placebo-controlled trial, hair loss reduced by 68.9% versus placebo. The follicle, no longer suppressed by elevated cortisol, recovers. Telogen percentage falls. Hair density improves not because a growth serum was applied, but because the follicle is doing what it was designed to do when the mechanism is addressed.

hair-density

Hair Density

In a 75-day randomised, double-blind, placebo-controlled study, hair density improved by 4.64%, reflecting a stronger and more active follicular environment. The follicle, no longer impacted by stress-mediated disruption, supports fuller, denser hair, not by external stimulation, but by restoring its natural growth function.

hair-growth

Hair Growth

Hair growth improved by 7.28%, supported by a measurable shift toward the anagen phase and reduced telogen percentage. Growth increases not because a stimulant was applied, but because the hair cycle is functioning as it was designed to when the underlying mechanism is addressed.

hair-nutrition

Scalp Nutrition

Cortisol constricts dermal vasculature, reducing blood flow to the follicle. As cortisol normalizes, scalp circulation recovers, improving the follicle’s nutritional environment. The follicle, no longer impacted by elevated cortisol, is better supported at the root, promoting stronger, more resilient hair through restored function, not external stimulation.

75-DAY DB-RCT · PUBLISHED

The follicle recovers. The published data confirms it.

0%

Reduction in hair loss (with bulb count)

0%

Reduction in telogen percentage

0%

Improvement in hair growth

0%

Improvement in hair density



black-wave